Quality evaluation of the management of oral anticoagulation therapy (OAT): The awareness of treating physicians and the education of patients needs to be improved

American Journal of Therapeutics

Volumn 13, Issue 3, 2006, Pages 223-228

  Gras Champel, Valérie ^a   Voyer, Annelise ^a   Guillaume, Nicolas ^a   Lematte, Céline ^a   Roussel, Bertrand ^a   Machu Prestaux, Charlotte ^a   Andréjak, Michel ^a   Lefrère, Jean Jacques ^a,b  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

Oral anticoagulant therapy; Quality evaluation; Vitamin K antagonists

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ALLOPURINOL; AMIODARONE; ANTICOAGULANT AGENT; CORTICOSTEROID; DICLOFENAC; ENOXAPARIN; FIBRIC ACID DERIVATIVE; FLUINDIONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MICONAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; SEROTONIN UPTAKE INHIBITOR; THYROID HORMONE; WARFARIN;

ADULT; AGED; ANEMIA; ANTICOAGULANT THERAPY; AORTA ANEURYSM; ARTICLE; AWARENESS; BLEEDING; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG SURVEILLANCE PROGRAM; EDUCATION PROGRAM; EPISTAXIS; FEMALE; FOOD DRUG INTERACTION; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE QUALITY; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HEMIPARESIS; HEMOPERITONEUM; HOSPITAL ADMISSION; HUMAN; INTRAOCULAR HEMORRHAGE; IRIDOCYCLITIS; JUGULAR VEIN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; PURPURA; RISK ASSESSMENT; SKIN MANIFESTATION; THROMBOSIS; TOOTH EXTRACTION; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VENOUS THROMBOEMBOLISM;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; FEMALE; HEMORRHAGE; HOSPITALIZATION; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PATIENT EDUCATION; PHYSICIAN'S ROLE; PROSPECTIVE STUDIES; QUALITY OF HEALTH CARE;

EID: 33745848807     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mjt.0000158339.08483.10     Document Type: Article

References (32)

1. Hyers TM, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease. Chest. 2001;119(Suppl):176S-193S.
2. Ridker PM, Goldhaber SZ, Danielson E, et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med. 2003;348:1425-1143.
3. Hirsh J, Poller L. The internationalized normalized ratio: a guide to understanding and correcting its problems. Arch Intern Med. 1994;154:282-288.
4. Ansell JE, Hirsh J, Dalen J, et al. Managing oral anticoagulation therapy. Chest. 2001;119:22S-38S.
5. Schulman S. Care of patients receiving long-term anticoagulant therapy. N Engl J Med. 2003;349:675-683.
6. Fitzmaurice DA, Machin SJ. Recommendations for patients undertaking self management of oral anticoagulation. BMG. 2001;323:985-989.
7. Pouyanne P, Haramburu F, Imbs JL, et al. Admissions to hospital caused by adverse drug reactions cross sectional incidence study. BMJ. 2000;320:1037-1039.
8. Hylek EM, Chang YC, Skates SJ, et al. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Arch Intern Med. 2000;160:1612-1617.
9. Fihn SD, Callahan CM, Martin DC, et al. The risk for and severity of bleeding complications in elderly patients treated with warfarin. Ann Intern Med. 1996;124:970-978.
10. Landefeld SC, Beyth RJ. Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med. 1993;95:315-327.
11. Bungard TJ, Ackman ML, Ho G, et al. Adequacy of anticoagulation in patients with atrial fibrillation coming to a hospital. Pharmacotherapy. 2000;20:1060-1065.
12. Oden A, Fahlen M. Oral anticoagulation and risk of death: a medical record linkage study. BMG. 2002;325:1073-1075.
13. Palareti G, Hirsh J, Legnani C, et al. Oral anticoagulation treatment in the elderly. A nested, prospective, case-control study. Arch Intern Med. 2000;160:470-478.
14. Hylek EM, Skates SJ, Sheehan MA, et al. An anlysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med. 1996;335:540-546.
15. Ansell JE. The quality of anticoagulation management. Arch Intern Med. 2000;160:895-896.
16. Samsa GP, Matchar D, Goldstein LB, et al. Quality of anticoagulation management among patients with atrial fibrillation. Arch Intern Med. 2000;160:967-973.
17. Holm T, Deutch S, Lassen JF, et al. Prospective evaluation of the quality of oral anticoagulation management in an outpatient clinic and general practices. Thromb Res. 2002;105:103-108.
18. Cannegieter SC, Rosendaal FR, Wintzen AR, et al. The optimal intensity of oral anticoagulant therapy in patients with mechanical heart valve prostheses: the Leiden artificial valve and anticoagulation study. N Engl J Med. 1995;333:11-17.
19. Levine MN, Raskob G, Kearon C. Hemorrhagic complications of anticoagulant treatment. Chest. 2001;119:108S-121S.
20. Kuijer PM, Hutten BA, Prins MH, et al. Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism. Arch Intern Med. 1999;159:457-460.
21. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med. 1994;120:897-902.
22. Franke CL, De Jonge J, Van Swieten JC, et al. Intracerebral hematomas during anticoagulant treatment. Stroke. 1990;21:726-730.
23. Butler AC, Tait RC. Management of oral anticoagulant-induced intracranial haemorrhage. Blood Rev. 1998;12:35-44.
24. Ansell JE. Anticoagulation management as a risk factor for adverse events: grounds for improvement. J Thromb Thrombolysis. 1998;5(Suppl):S13-S18.
25. Hart RG, Bradley SB, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypothese. Stroke. 1995;26:1471-1477.
26. Palareti G, Manotti C, D'Angelo A, et al. Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT Study. Thromb Haemost. 1997;78:1438-1443.
27. Arnsten JH, Gelfland JM, Singer DE. Determinants of compliance with anticoagulation: a case-control study. Am J Med. 1997;103:11-17.
28. Tang EO, Lee CK, Wong R, et al. Relationship between patients' warfarin knowledge and anticoagulation control. Ann Pharmacother. 2003;37:34-38.
29. Estrada CA, Mryniewicz M, Barnes Higgs V, et al. Anticoagulant patients information material is written at high readability levels. Stroke. 2000;31:2966-2970.
30. Gazmararian J, Baker DW, Williams MV, et al. Health literacy among medicare enrollees in managed care organization. JAMA. 1999;281:545-551.
31. Smith H, Gooding S, Brown R, et al. Evaluation of readability and accuracy of information leaflets in general practice for patients with asthma. BMJ. 1998;317:264-265.
32. Van der Meer FJM, Briet P, Vandenbroucke JP, et al. The role of compliance as a cause of instability in oral anticoagulant therapy. Br J Haematol. 1997;98:893-900.